Commentary Highlights Advantages of Molecular Stool Testing

10月 24th, 2014 / Nanosphere, A Luminex Company

Over the past few months, we have shared a number of educational pieces that have described the challenges associated with conventional methodologies for the detection of community-acquired diarrheal illness and the potential benefits of rapid molecular tests.

One commentary in particular that best speak to these matters include an editorial in Medical Laboratory Observer titled “The Changing Landscape of Diagnostic Testing for Diarrheal Disease.” This piece articulately summarizes the burden of diarrheal illness in the U.S., the limitations associated with conventional stool testing practices, and the value of molecular testing for diarrheal illness.

Click here for a link to the MLO editorial

Learn More About the Verigene® Enteric Pathogens Test (EP)